J. Gassman

发表

Data quality assurance, monitoring, and reporting.

J. Gassman, W. W. Owen, T. Kuntz, 1995, Controlled clinical trials.

Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.

Jackson T. Wright, L. Appel, L. Agodoa, 2006, Archives of internal medicine.

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.

A. Cheung, M. Wolf, J. Kusek, 2015, Journal of the American Society of Nephrology : JASN.

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Keith C. Norris, G. Beck, Mahboob Rahman, 2001, JAMA.

Design and statistical issues of the hemodialysis (HEMO) study.

N W Levin, G. Beck, G. Eknoyan, 2000, Controlled clinical trials.

Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKD.

A. Cheung, M. Wolf, A. Srivastava, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Objectives and design of the hemodialysis fistula maturation study.

G. Beck, A. Cheung, T. Greene, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Kidneys of the killerwhale and significance of reniculism

J. Gassman, N. Maluf, 1998, The Anatomical record.

Cancer of the esophagus. The Cleveland Clinic experience.

D. Cosgrove, S. Galandiuk, J. Gassman, 1986, Annals of surgery.

Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group

T. Srivastava, D. Gipson, H. Trachtman, 2015, BMC Nephrology.

Vascular Function at Baseline in the Hemodialysis Fistula Maturation Study

G. Beck, A. Cheung, S. Berceli, 2016, Journal of the American Heart Association.

Abnormalities in Cardiac Structure and Function among Individuals with CKD: The COMBINE Trial

M. Wolf, L. Fried, M. Chonchol, 2021, Kidney360.

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Tom Greene, Lawrence J Appel, Lee Hebert, 2002, JAMA.

Improvement in Kidney Function: A Real Occurrence

G. Eknoyan, S. Rajagopalan, T. Hostetter, 2012 .

Recruitment of African Americans With Chronic Renal Insufficiency Into a Multicenter Clinical Trial: The African American Study of Kidney Disease and Hypertension

J. Kusek, K. Norris, A. Ojo, 2004, Journal of clinical hypertension.

Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans.

L. Appel, L. Agodoa, E. Miller, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Ramipril delays progression of hypertensive renal disease more than amlodipine

G. Bakris, S. Massry, J. Kusek, 2001 .

56A Comparison of time-to-event and slope-based analyses in nephrology clinical trials

G. Beck, M. Kutner, T. Greene, 1995 .

Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group.

A. Levey, W. G. Walker, J. Gassman, 1991, Journal of the American Society of Nephrology : JASN.

Design of the Blood Pressure Goals in Dialysis Pilot Study

E. Bedrick, M. Unruh, J. Kusek, 2014, The American journal of the medical sciences.

Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.

T. Greene, D. Gipson, M. Moxey-Mims, 2011, Kidney international.

Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study.

M. Rocco, R. Kaplan, J. Gassman, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial.

A. Cheung, T. Hostetter, M. Wolf, 2019, Journal of the American Society of Nephrology : JASN.

Reduction of dietary protein and phosphorus in the Modification of Diet in Renal Disease Feasibility Study. The MDRD Study Group.

L. Snetselaar, R. Berg, J. Dwyer, 1994, Journal of the American Dietetic Association.

The spectrum of infection-related morbidity in hospitalized haemodialysis patients.

S. Beddhu, J. Gassman, G. Kaysen, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.

D. Gipson, C. Spino, J. Troost, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.

A. Cheung, M. Wolf, L. Fried, 2019, Journal of the American Society of Nephrology : JASN.

Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.

C. Winkler, V. D’Agati, D. Gipson, 2015, Journal of the American Society of Nephrology : JASN.

Association of histologic variants in FSGS clinical trial with presenting features and outcomes.

V. D’Agati, T. Greene, C. Alpers, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease.

Anna C. Porter, Tom Greene, Keith C. Norris, 2012, Translational research : the journal of laboratory and clinical medicine.

Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease.

Lawrence Appel, Tom Greene, Janice Lea, 2006, Journal of the American Society of Nephrology : JASN.

Patient Recruitment into a Multicenter Randomized Clinical Trial  for Kidney Disease: Report of the Focal Segmental Glomerulosclerosis Clinical Trial (FSGS CT)

Amita Sharma, D. Gipson, M. Moxey-Mims, 2013, Clinical and translational science.

Multicenter Study Evaluating Intrarenal Oxygenation and Fibrosis Using Magnetic Resonance Imaging in Individuals With Advanced CKD

A. Cheung, M. Wolf, L. Fried, 2018, Kidney international reports.

Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration.

M. Rocco, A. Levey, J. Lewis, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Clinical trial of focal segmental glomerulosclerosis in children and young adults.

V. D’Agati, T. Greene, D. Gipson, 2011, Kidney international.

Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials

Christopher T. Chan, G. Beck, A. Garg, 2015, Hemodialysis international. International Symposium on Home Hemodialysis.

Circulating suPAR in two cohorts of primary FSGS.

A. Anarat, D. Gipson, G. Ghiggeri, 2012, Journal of the American Society of Nephrology : JASN.

Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD.

Jackson T. Wright, Mahboob Rahman, L. Appel, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.

T. Greene, T. Srivastava, D. Gipson, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Intensive blood-pressure control in hypertensive chronic kidney disease.

Keith C. Norris, Jackson T. Wright, B. Astor, 2010, The New England journal of medicine.

The modification of diet in renal disease study group

George W. Williams, Richard L. Berg, Cecil H. Coggins, 1991 .

A Patient With CKD Develops Cholestatic Liver Injury During a Clinical Trial

A. Cheung, M. Wolf, C. Martínez, 2017, Kidney international reports.

The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials.

A. Garg, P. Kimmel, M. Unruh, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.

G. Beck, J. Kaufman, M. Rocco, 2008, JAMA.

Depressive Symptoms Associate With Race and All-Cause Mortality in Patients With CKD

Keith C. Norris, F. Lin, J. Gassman, 2018, Kidney international reports.

Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study.

S. Beddhu, J. Gassman, G. Kaysen, 2003, Journal of the American Society of Nephrology : JASN.

Impact of Sleep Quality on Cardiovascular Outcomes in Hemodialysis Patients: Results from the Frequent Hemodialysis Network Study

Christopher T. Chan, M. Unruh, A. Kliger, 2011, American Journal of Nephrology.

Effect of dipyridamole plus aspirin on hemodialysis graft patency.

G. Beck, J. Kaufman, T. Ikizler, 2009, The New England journal of medicine.

Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.

Keith C. Norris, L. Appel, J. Lewis, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The rationale and design of the AASK cohort study.

Keith C. Norris, L. Appel, G. Bakris, 2003, Journal of the American Society of Nephrology : JASN.

Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.

L. Appel, D. Glidden, A. Parsa, 2017, Kidney international.

Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group.

A. Levey, R. Berg, W. G. Walker, 1989, Kidney international. Supplement.

N-Terminal Prohormone Brain Natriuretic Peptide as a Predictor of Cardiovascular Disease and Mortality in Blacks With Hypertensive Kidney Disease: The African American Study of Kidney Disease and Hypertension (AASK)

B. Astor, L. Appel, G. Bakris, 2008, Circulation.

In-center hemodialysis six times per week versus three times per week.

G. Beck, M. Rocco, S. Rajagopalan, 2010, The New England journal of medicine.

Risk of vascular access complications with frequent hemodialysis.

M. Rocco, A. Kliger, P. Eggers, 2013, Journal of the American Society of Nephrology : JASN.

Complement Activation in Patients with Focal Segmental Glomerulosclerosis

D. Gipson, J. Thurman, H. Trachtman, 2015, PloS one.

BP in Dialysis: Results of a Pilot Study.

Mahboob Rahman, A. Levey, R. Kwong, 2017, Journal of the American Society of Nephrology : JASN.

Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.

Mahboob Rahman, Tom Greene, Lawrence J Appel, 2008, Archives of internal medicine.

Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study.

L. Appel, T. Erlinger, J. Lewis, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).

M. Kutner, G. Beck, G. Bakris, 2003, Journal of the American Society of Nephrology : JASN.

Design and Rationale of Health-Related Quality of Life and Patient-Reported Outcomes Assessment in the Frequent Hemodialysis Network Trials

A. Garg, P. Kimmel, M. Unruh, 2011, Blood Purification.

Acute Declines in Renal Function during Intensive BP Lowering and Long-Term Risk of Death.

N. Tangri, M. Sarnak, J. Ix, 2018, Journal of the American Society of Nephrology : JASN.

Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk.

G. Bakris, K. Johansen, V. Campese, 2017, Journal of the American Society of Nephrology : JASN.

BP Control and Long-Term Risk of ESRD and Mortality.

L. Appel, G. Bakris, D. Glidden, 2017, Journal of the American Society of Nephrology : JASN.

Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study.

A. Levey, T. Greene, J. Gassman, 1997, Kidney international.

Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study.

Mahboob Rahman, L. Ruilope, R. Townsend, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease.

B. Astor, T. Erlinger, G. Bakris, 2010, Journal of the American Society of Nephrology : JASN.

Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials.

A. Nissenson, J. Stokes, M. Unruh, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.

L. Appel, G. Bakris, T. Greene, 2009, Archives of internal medicine.

Kidney function can improve in patients with hypertensive CKD.

B. Astor, L. Appel, J. Lewis, 2012, Journal of the American Society of Nephrology : JASN.

A Simple Equation to Estimate Urinary Flow Rate Using Urine Creatinine

S. Weisbord, L. Fried, J. Ix, 2020, American Journal of Nephrology.

Relationship between volume status and blood pressure during chronic hemodialysis.

John K Leypoldt, Nathan W Levin, M. Rocco, 2002, Kidney international.

Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease.

Keith C. Norris, P. Kimmel, T. Greene, 2011, Kidney international.

Association of Shear Stress with Subsequent Lumen Remodeling in Hemodialysis Arteriovenous Fistulas

A. Cheung, S. Berceli, Y. Shiu, 2022, Clinical journal of the American Society of Nephrology : CJASN.

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.

Christopher T. Chan, G. Eknoyan, M. Rocco, 2011, Kidney international.

Frequent Hemodialysis Network (FHN) randomized trials: study design.

G. Beck, A. Garg, M. Rocco, 2007, Kidney international.

Quality of life and outcomes in African Americans with CKD.

Anna C. Porter, Keith C. Norris, T. Greene, 2014, Journal of the American Society of Nephrology : JASN.

Design of the Dialysis Access Consortium (DAC) clopidogrel prevention of early AV fistula thrombosis trial

G. Beck, T. Greene, H. Feldman, 2005, Clinical trials.

Design of the Dialysis Access Consortium (DAC) Aggrenox prevention of access stenosis trial

G. Beck, T. Greene, H. Feldman, 2005, Clinical trials.

Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials.

A. Garg, P. Kimmel, M. Unruh, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study.

J. Kusek, T. Steinman, J. Gassman, 1991, Controlled clinical trials.

Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design

T. Greene, D. Gipson, H. Trachtman, 2011, BMC nephrology.

Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease.

Keith C. Norris, P. Kimmel, T. Greene, 2010, Kidney international.

Administration of Study Treatments and Participant Follow-Up

J. Gassman, 2021 .

Dynamic Remodeling of Human Arteriovenous Fistula Wall Obtained From Magnetic Resonance Imaging During the First 6 Months After Creation

J. Kaufman, S. Berceli, J. Kusek, 2022, Kidney international reports.

F. V. Lente, G. Bakris, J. Lash, 2008, Circulation.

Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group.

L. Hunsicker, J. Gassman, C. Coggins, 1991, Controlled clinical trials.

Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.

J. Kaufman, M. Rocco, T. Ikizler, 2008, JAMA.

Comparison of Dialysis Unit and Home Blood Pressures: An Observational Cohort Study.

V. Pankratz, R. Kwong, D. Miskulin, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.